The invention belongs to the technical field of chemical
raw material medicines, and particularly relates to an
aryl alkyl amine compound as well as a preparation method and application thereof. The structure of the
aryl alkyl amine compound is shown as a formula I. Experiments prove that the allosteric
agonist effect of the compound provided by the invention on a
calcium-sensitive
receptor is superior to or equivalent to that of Evocalpet, and the
aryl alkyl amine compound has potential in preparation of drugs for treating
secondary hyperparathyroidism. Formula I